172 related articles for article (PubMed ID: 3012593)
21. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
Robertson HA
Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
[TBL] [Abstract][Full Text] [Related]
22. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
23. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
[TBL] [Abstract][Full Text] [Related]
24. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M
Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097
[TBL] [Abstract][Full Text] [Related]
25. Decreased activity of striatal monoamine oxidase B after rapid eye movement (REM) sleep deprivation in rats.
Perez NM; Mattei R; Benedito MA
Pharmacol Biochem Behav; 1998 May; 60(1):33-7. PubMed ID: 9610921
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
Howlett DR; Nahorski SR
FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
[No Abstract] [Full Text] [Related]
27. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes.
Golembiowska-Nikitin K; Pilc A; Vetulani J
Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):140-1. PubMed ID: 7202125
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
Zahniser NR; Molinoff PB
Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
[TBL] [Abstract][Full Text] [Related]
29. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
Tachizawa H; Sudo K; Sano M
Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
[TBL] [Abstract][Full Text] [Related]
30. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
Riffee WH; Wilcox RE; Vaughn DM; Smith RV
Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
[TBL] [Abstract][Full Text] [Related]
31. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
32. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
Lazareno S; Nahorski SR
Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
[TBL] [Abstract][Full Text] [Related]
33. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
Hamblin MW; Leff SE; Creese I
Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
[TBL] [Abstract][Full Text] [Related]
34. 3H-Spiroperidol binding to striatal membranes of mutant Han-Wistar rats which exhibit spastic paresis.
Golombiowska-Nikitin K; Sontag KH; Osborne NN
Experientia; 1981 May; 37(5):490-1. PubMed ID: 7250319
[TBL] [Abstract][Full Text] [Related]
35. Effects of phospholipids on the specific binding of [3H]spiroperidol to the cholate extract of rat brain synaptic membranes.
Moroi K; Hsu LL
Int J Biochem; 1985; 17(5):637-44. PubMed ID: 4029482
[TBL] [Abstract][Full Text] [Related]
36. [3H]Spiperone binding in the rat striatum during the development of physical dependence on phencyclidine and after withdrawal.
Spain JW; Klingman GI; Hruska RE
Neurosci Lett; 1985 Jul; 58(1):67-72. PubMed ID: 2931624
[TBL] [Abstract][Full Text] [Related]
37. Effects of REM sleep deprivation and desipramine on beta-adrenergic binding sites in rat brain.
Radulovacki M; Micovic N
Brain Res; 1982 Mar; 235(2):393-6. PubMed ID: 6329418
[TBL] [Abstract][Full Text] [Related]
38. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
Noisin EL; Thomas WE
Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
[TBL] [Abstract][Full Text] [Related]
39. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
Ritzmann RF; Lee JM; Fields JZ
Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
[No Abstract] [Full Text] [Related]
40. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
